Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022
Accounts payable	$ (996)	$ (24,573)	$ 22,856
Accrued expenses and other current liabilities	(7,104)	2,671	8,316
Deferred revenue	12,307	(418)	(8,799)
Proceeds from exercise of stock options	909	4,203	16,998
Proceeds from PIPE	0	0	250,000
Related Party
Accounts payable	623	(9,381)	8,145
Accrued expenses and other current liabilities	(1,986)	2,966	(1,293)
Deferred revenue	9,246	2,572	(20,959)
Proceeds from PIPE	$ 0	$ 0	$ 25,000